Daubert v. Merrell Dow Pharmaceuticals, Inc.

ELR Citation: ELR 20856
No(s). 90-5537 (9th Cir. Jan 4, 1995)

On remand from the U.S. Supreme Court, the court holds inadmissible under Fed. R. Evid. 702 expert testimony offered to prove that plaintiffs' mothers' ingestion of the drug Bendectin during pregnancy caused the plaintiffs to be born with limb-reduction birth defects. The court first refuses to rema...

You must be an ELR subscriber to access the full content.

You are not logged in. To access this content: